After two miscarriages, couple Talia and Dan worried whether they could conceive a healthy child. The third time they became pregnant, they tried noninvasive prenatal testing (NIPT)—a screening test from Illumina. The test screens for multiple fetal chromosomal aneuploidies using a single maternal blood draw. The couple reflects on the value of NIPT and its ability to provide couples like them with more accurate answers. Learn more about the latest advances in reproductive and genetic health solutions from Illumina. http://www.illumina.com/clinical/reproductive-genetic-health.ilmn